403 related articles for article (PubMed ID: 3053901)
21. Reduction of macrophage-mediated tumor cytotoxicity by pretreatment with GM-CSF.
Heidenreich S; Gong JH; Nain M; Gemsa D
Behring Inst Mitt; 1988 Aug; (83):274-7. PubMed ID: 3149190
[TBL] [Abstract][Full Text] [Related]
22. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
[TBL] [Abstract][Full Text] [Related]
23. Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells.
Lindemann A; Riedel D; Oster W; Mertelsmann R; Herrmann F
Eur J Immunol; 1988 Mar; 18(3):369-74. PubMed ID: 3281850
[TBL] [Abstract][Full Text] [Related]
24. Human granulocyte-macrophage colony-stimulating factor plus phorbol myristate acetate stimulate a promyelocytic cell line to produce an IL-1 inhibitor.
Mazzei GJ; Bernasconi LM; Lewis C; Mermod JJ; Kindler V; Shaw AR
J Immunol; 1990 Jul; 145(2):585-91. PubMed ID: 2142181
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
[TBL] [Abstract][Full Text] [Related]
26. Macrophage growth factor CSF-1 stimulates human monocyte production of interferon, tumor necrosis factor, and colony stimulating activity.
Warren MK; Ralph P
J Immunol; 1986 Oct; 137(7):2281-5. PubMed ID: 2428865
[TBL] [Abstract][Full Text] [Related]
27. Effect of human recombinant granulocyte-macrophage colony-stimulating factor and IL-3 on the expression of surface markers of human monocyte-derived macrophages in long-term cultures.
Dimri R; Nissimov L; Keisari Y
Lymphokine Cytokine Res; 1994 Aug; 13(4):239-45. PubMed ID: 7528061
[TBL] [Abstract][Full Text] [Related]
28. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
[TBL] [Abstract][Full Text] [Related]
29. Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor.
Sabatini M; Chavez J; Mundy GR; Bonewald LF
Cancer Res; 1990 May; 50(9):2673-8. PubMed ID: 2183930
[TBL] [Abstract][Full Text] [Related]
30. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
Frey JR; Kamber M; Peck R
Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
[TBL] [Abstract][Full Text] [Related]
31. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
32. Regulation by interleukin-3 of human monocyte pro-inflammatory mediators. Similarities with granulocyte-macrophage colony-stimulating factor.
Hart PH; Whitty GA; Burgess DR; Hamilton JA
Immunology; 1990 Sep; 71(1):76-82. PubMed ID: 2120130
[TBL] [Abstract][Full Text] [Related]
33. Effects of recombinant human colony stimulating factors (CSF) (granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human monocyte/macrophage differentiation.
Geissler K; Harrington M; Srivastava C; Leemhuis T; Tricot G; Broxmeyer HE
J Immunol; 1989 Jul; 143(1):140-6. PubMed ID: 2471733
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
35. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
36. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
37. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of granulocyte-macrophage colony-stimulating factor and macrophage colony-stimulating factor on tumor necrosis factor and interleukin-1 production in human monocytes.
Essner R; Rhoades K; McBride WH; Morton DL; Economou JS
J Clin Lab Immunol; 1990 Aug; 32(4):161-6. PubMed ID: 1966932
[TBL] [Abstract][Full Text] [Related]
39. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF.
Philip R
J Immunol; 1988 Feb; 140(4):1345-9. PubMed ID: 2449501
[TBL] [Abstract][Full Text] [Related]
40. A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3.
Maeda K; Sone S; Ohmoto Y; Ogura T
J Immunol; 1991 Jun; 146(11):3779-84. PubMed ID: 1903413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
